Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban versus unfractionated heparin during elective PCI in coronary artery disease patients with moderate to high bleeding risk
ChiCTR-TRC-11001770Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis and unstable angina comparing Heparin arm with Argatroban arm (2 arms). Primary endpoint: Activated clotting time. Started Jan 2012; status: completed.
02
Drugs
argatrobanheparin
03
Conditions
coronary arteriosclerosisunstable angina
Beyond the preview
Go deeper on ChiCTR-TRC-11001770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001770.